INM: Inmed Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Inmed Pharmaceuticals Inc (INM).
$2.22M Market Cap.
INM Market Cap. (MRY)
INM Shares Outstanding (MRY)
INM Assets (MRY)
Total Assets
$11.82M
Total Liabilities
$2.62M
Total Investments
$43.06K
INM Income (MRY)
Revenue
$4.60M
Net Income
-$7.68M
Operating Expense
$9.24M
INM Cash Flow (MRY)
CF Operations
-$6.99M
CF Investing
-$9.29K
CF Financing
$4.65M
INM Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $11,822,782 (-16.19%) | $14,106,340 (10.31%) | $12,787,580 (30.74%) | $9,781,216 (25.36%) |
Assets Current | $8,689,585 (-23.32%) | $11,331,727 (18.07%) | $9,597,776 (14.56%) | $8,378,269 (32.73%) |
Assets Non-Current | $3,133,197 (12.92%) | $2,774,613 (-13.02%) | $3,189,804 (127.36%) | $1,402,947 (-5.85%) |
Goodwill & Intangible Assets | $1,783,198 (-8.38%) | $1,946,279 (-7.71%) | $2,108,915 (98.64%) | $1,061,697 (-2.30%) |
Shareholders Equity | $9,206,109 (-23.85%) | $12,089,727 (33.17%) | $9,078,541 (23.07%) | $7,376,567 (25.49%) |
Property Plant & Equipment Net | $1,249,999 (72.79%) | $723,426 (-20.00%) | $904,252 (176.87%) | $326,595 (-19.06%) |
Cash & Equivalents | $6,571,610 (-26.27%) | $8,912,517 (44.29%) | $6,176,866 (-16.11%) | $7,363,126 (26.82%) |
Accumulated Other Comprehensive Income | $128,569 (0.00%) | $128,569 (0.00%) | $128,569 (0.00%) | $128,569 (142.59%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $43,064 (-3.06%) | $44,422 (-0.85%) | $44,804 (-3.57%) | $46,462 (9.62%) |
Investments Current | $43,064 (-3.06%) | $44,422 (-0.85%) | $44,804 (-3.57%) | $46,462 (9.62%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $1,244,324 (-23.02%) | $1,616,356 (-35.11%) | $2,490,854 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $352,838 (35.50%) | $260,399 (195.82%) | $88,027 (638.54%) | $11,919 (-73.71%) |
Trade & Non-Trade Payables | $1,654,011 (2.81%) | $1,608,735 (-44.82%) | $2,915,265 (36.55%) | $2,134,878 (32.82%) |
Accumulated Retained Earnings (Deficit) | -$109,075,759 (-7.57%) | -$101,400,209 (-8.50%) | -$93,452,587 (-24.85%) | -$74,852,470 (-15.78%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $962,662 (156.22%) | $375,713 (-7.07%) | $404,276 (49.86%) | $269,771 (-14.89%) |
Debt Current | $317,797 (-15.41%) | $375,713 (-7.07%) | $404,276 (402.31%) | $80,483 (16.70%) |
Debt Non-Current | $644,865 (0%) | $0 (0%) | $0 (0%) | $189,288 (-23.68%) |
Total Liabilities | $2,616,673 (29.76%) | $2,016,613 (-45.63%) | $3,709,039 (54.24%) | $2,404,649 (24.96%) |
Liabilities Current | $1,971,808 (-1.44%) | $2,000,619 (-39.73%) | $3,319,541 (49.84%) | $2,215,361 (32.16%) |
Liabilities Non-Current | $644,865 (3931.92%) | $15,994 (-95.89%) | $389,498 (105.77%) | $189,288 (-23.68%) |
INM Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $4,597,730 (11.18%) | $4,135,561 (279.61%) | $1,089,435 (0%) | $0 (0%) |
Cost of Revenue | $3,496,817 (27.97%) | $2,732,525 (400.56%) | $545,889 (0%) | $0 (0%) |
Selling General & Administrative Expense | $5,250,715 (-10.21%) | $5,847,518 (-14.85%) | $6,867,030 (53.30%) | $4,479,333 (38.80%) |
Research & Development Expense | $3,765,028 (0.88%) | $3,732,056 (-48.75%) | $7,282,615 (36.43%) | $5,338,084 (-8.14%) |
Operating Expenses | $9,235,343 (-5.59%) | $9,781,823 (-45.07%) | $17,807,895 (79.18%) | $9,938,283 (8.60%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $360,350 (0%) |
Income Tax Expense | $7,100 (-45.80%) | $13,100 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$7,675,550 (3.42%) | -$7,947,622 (57.27%) | -$18,600,117 (-82.30%) | -$10,203,089 (-14.14%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$7,675,550 (3.42%) | -$7,947,622 (57.27%) | -$18,600,117 (-82.30%) | -$10,203,089 (-14.14%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$7,675,550 (3.42%) | -$7,947,622 (57.27%) | -$18,600,117 (-82.30%) | -$10,203,089 (-14.14%) |
Weighted Average Shares | $381,054 (211.26%) | $122,423 (336.59%) | $28,041 (108.64%) | $13,440 (28.72%) |
Weighted Average Shares Diluted | $381,054 (211.26%) | $122,423 (336.59%) | $28,041 (108.64%) | $13,440 (28.72%) |
Earning Before Interest & Taxes (EBIT) | -$7,668,450 (3.35%) | -$7,934,522 (57.34%) | -$18,600,117 (-88.97%) | -$9,842,739 (-10.11%) |
Gross Profit | $1,100,913 (-21.53%) | $1,403,036 (158.13%) | $543,546 (0%) | $0 (0%) |
Operating Income | -$8,134,430 (2.92%) | -$8,378,787 (51.47%) | -$17,264,349 (-73.72%) | -$9,938,283 (-8.60%) |
INM Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$9,293 (98.60%) | -$661,804 (1.66%) | -$672,999 (-38914.43%) | -$1,725 (-100.05%) |
Net Cash Flow from Financing | $4,654,218 (-56.42%) | $10,680,654 (-29.13%) | $15,070,497 (38.84%) | $10,854,722 (35123.14%) |
Net Cash Flow from Operations | -$6,985,832 (4.08%) | -$7,283,199 (53.26%) | -$15,583,758 (-59.17%) | -$9,790,640 (-32.76%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$2,340,907 (-185.57%) | $2,735,651 (330.61%) | -$1,186,260 (-176.17%) | $1,557,317 (138.63%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | -$500,000 (-139.36%) | -$208,891 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$425,000 (0%) | $0 (0%) |
Capital Expenditure | -$9,293 (94.26%) | -$161,804 (-313.74%) | -$39,108 (-2167.13%) | -$1,725 (95.90%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | -$290,826 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $4,654,043 (-56.42%) | $10,680,008 (-37.71%) | $17,146,114 (37.47%) | $12,472,500 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $494,960 (218.88%) |
Share Based Compensation | $137,714 (-50.49%) | $278,155 (-60.14%) | $697,894 (14.37%) | $610,193 (-38.64%) |
Depreciation Amortization & Accretion | $604,518 (1.43%) | $595,997 (16.45%) | $511,790 (123.79%) | $228,694 (13.08%) |
INM Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 23.90% (-29.50%) | 33.90% (-32.06%) | 49.90% | - |
Profit Margin | -166.90% (13.16%) | -192.20% (88.74%) | -1707.30% | - |
EBITDA Margin | -153.60% (13.42%) | -177.40% (89.32%) | -1660.30% | - |
Return on Average Equity (ROAE) | -72.00% (-12.85%) | -63.80% (57.66%) | -150.70% (-10.32%) | -136.60% (-53.66%) |
Return on Average Assets (ROAA) | -59.80% (-13.47%) | -52.70% (53.97%) | -114.50% (-13.59%) | -100.80% (-31.08%) |
Return on Sales (ROS) | -166.80% (13.08%) | -191.90% (88.76%) | -1707.30% | - |
Return on Invested Capital (ROIC) | -341.70% (46.68%) | -640.90% (74.12%) | -2476.80% (-224.18%) | 1994.60% (405.17%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.26 (7.72%) | -0.28 (19.72%) | -0.35 (83.05%) | -2.09 |
Price to Sales Ratio (P/S) | 0.44 (-19.85%) | 0.55 (-90.93%) | 6.05 | - |
Price to Book Ratio (P/B) | 0.24 (-5.49%) | 0.26 (-66.40%) | 0.76 (-78.13%) | 3.47 |
Debt to Equity Ratio (D/E) | 0.28 (70.06%) | 0.17 (-59.17%) | 0.41 (25.46%) | 0.33 (-0.31%) |
Earnings Per Share (EPS) | -20.2 (68.92%) | -65 (90.20%) | -663.4 (12.62%) | -759.2 (11.20%) |
Sales Per Share (SPS) | 12.07 (-64.28%) | 33.78 (-13.05%) | 38.85 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -18.36 (69.81%) | -60.81 (89.08%) | -557.13 (23.54%) | -728.62 (-2.58%) |
Book Value Per Share (BVPS) | 24.16 (-75.54%) | 98.75 (-69.50%) | 323.75 (-41.01%) | 548.87 (-2.51%) |
Tangible Assets Book Value Per Share (TABVPS) | 26.35 (-73.47%) | 99.33 (-73.92%) | 380.82 (-41.30%) | 648.79 (0.87%) |
Enterprise Value Over EBIT (EV/EBIT) | 1 (0.00%) | 1 (0%) | 0 (0%) | -2 |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.71 (-14.20%) | 0.83 (883.96%) | -0.11 (93.80%) | -1.71 |
Asset Turnover | 0.36 (30.66%) | 0.27 (308.96%) | 0.07 (0%) | 0 (0%) |
Current Ratio | 4.41 (-22.19%) | 5.66 (95.92%) | 2.89 (-23.56%) | 3.78 (0.42%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$6,995,125 (6.04%) | -$7,445,003 (52.35%) | -$15,622,866 (-59.54%) | -$9,792,365 (-32.03%) |
Enterprise Value (EV) | -$5,036,016 (17.40%) | -$6,096,914 (-418.89%) | $1,911,895 (-88.37%) | $16,442,187 |
Earnings Before Tax (EBT) | -$7,668,450 (3.35%) | -$7,934,522 (57.34%) | -$18,600,117 (-82.30%) | -$10,203,089 (-14.14%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$7,063,932 (3.74%) | -$7,338,525 (59.43%) | -$18,088,327 (-88.14%) | -$9,614,045 (-10.04%) |
Invested Capital | $2,458,828 (51.53%) | $1,622,638 (2.28%) | $1,586,534 (369.27%) | -$589,197 (-31.18%) |
Working Capital | $6,717,777 (-28.01%) | $9,331,108 (48.63%) | $6,278,235 (1.87%) | $6,162,908 (32.93%) |
Tangible Asset Value | $10,039,584 (-17.44%) | $12,160,061 (13.87%) | $10,678,665 (22.47%) | $8,719,519 (29.83%) |
Market Capitalization | $2,219,037 (-28.04%) | $3,083,569 (-55.23%) | $6,887,430 (-73.10%) | $25,601,248 |
Average Equity | $10,665,265 (-14.37%) | $12,455,089 (0.94%) | $12,338,565 (65.20%) | $7,468,974 (-25.76%) |
Average Assets | $12,838,575 (-14.89%) | $15,085,117 (-7.15%) | $16,246,090 (60.55%) | $10,119,328 (-12.91%) |
Invested Capital Average | $2,244,346 (81.29%) | $1,237,986 (64.85%) | $750,961 (252.18%) | -$493,471 (-136.08%) |
Shares | 417,898 (151.13%) | 166,410 (468.28%) | 29,283 (81.87%) | 16,101 (5.35%) |
